ISPC

+ Watchlist + Portfolio

iSpecimen Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $2.38
52-Week Range: $1.77 – $127.20
Market Cap: $5.72M
P/E (TTM): —
EPS (TTM): -50.48
Dividend Yield: —

Advanced Metrics

Price/Book: 0.16
PEG Ratio: —
Return on Equity: -894.59%
Return on Assets: -91.78%
Gross Margin: -29.64%
Operating Margin: -1627.09%
Profit Margin: 0.00%
Current Ratio: 0.62
Debt/Equity: 0.31
Total Debt: $254.99K
Free Cash Flow: $-5.69M
Revenue Growth: -85.20%
Earnings Growth: —
Enterprise Value: $669.60K

ISPC Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$10.40M	$9.93M	$9.29M	$1.93M
Cost of Revenue	$4.76M	$4.82M	$5.30M	$1.90M
Gross Profit	$5.65M	$5.11M	$3.99M	$24.11K
Research & Development	$2.66M	$3.57M	$3.53M	$2.16M
Selling, General & Admin	$12.37M	$11.68M	$12.65M	$6.60M
Operating Expenses	$15.83M	$16.28M	$16.72M	$9.00M
Operating Income	-$10.19M	-$11.17M	-$12.73M	-$8.98M
EBITDA	-$8.80M	-$8.75M	-$9.98M	-$8.75M
Pretax Income	-$10.25M	-$11.10M	-$12.50M	-$10.49M
Net Income	-$10.25M	-$11.10M	-$12.50M	-$10.49M
Diluted EPS	-928.00	-982.00	-703.20	-91.20
Diluted Shares	11055	11301	17771	115061

ISPC Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$15.31M	$2.34M	$1.88M	$6.88M
Receivables	$4.07M	$2.94M	$1.44M	$48.30K
Inventory	—	—	$45.11K	$0.00
Current Assets	$19.68M	$8.24M	$3.59M	$6.95M
Total Assets	$24.62M	$15.82M	$9.35M	$9.53M
Current Liabilities	$4.28M	$6.05M	$5.77M	$6.23M
Total Debt	$185.85K	$196.24K	$312.17K	$268.80K
Total Liabilities	$4.31M	$6.08M	$6.04M	$6.44M
Retained Earnings	-$48.27M	-$59.36M	-$71.86M	-$82.35M
Shareholders' Equity	$20.31M	$9.74M	$3.31M	$3.09M
Working Capital	$15.39M	$2.19M	-$2.18M	$723.28K

ISPC Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$5.82M	-$5.81M	-$8.26M	-$4.24M
Capital Expenditure	-$3.19M	-$4.74M	-$709.83K	-$1.00M
Free Cash Flow	-$9.01M	-$10.55M	-$8.97M	-$5.24M
Depreciation & Amortisation	$1.21M	$2.12M	$2.29M	$1.73M
Stock-Based Compensation	$678.61K	$459.67K	$249.68K	$21.27K
Investing Cash Flow	-$3.19M	-$7.23M	$1.98M	-$1.00M
Financing Cash Flow	-$3.42M	$70.89K	$5.82M	$10.24M
Net Change in Cash	-$12.43M	-$12.97M	-$465.26K	$5.00M

ISPC Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$1.06M	$713.13K	$106.59K	$51.76K	$156.01K
Cost of Revenue	$657.28K	$444.18K	$204.59K	$598.84K	$84.41K
Gross Profit	$400.23K	$268.96K	-$98.00K	-$547.08K	$71.60K
Research & Development	$545.37K	$536.31K	$551.10K	$527.03K	$247.55K
Selling, General & Admin	$1.11M	$1.21M	$2.00M	$2.28M	$2.22M
Operating Expenses	$2.04M	$2.09M	$2.73M	$2.14M	$2.61M
Operating Income	-$1.64M	-$1.82M	-$2.83M	-$2.69M	-$2.54M
EBITDA	-$1.21M	-$614.51K	-$2.32M	-$4.59M	-$2.14M
Pretax Income	-$1.66M	-$1.05M	-$2.78M	-$5.00M	-$2.28M
Net Income	-$1.66M	-$1.05M	-$2.78M	-$5.00M	-$2.28M
Diluted EPS	-28.55	-16.80	-19.20	—	-266.40
Diluted Shares	58078	62421	145989	—	8534

ISPC Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$782.56K	$588.77K	$2.78M	$6.88M	$2.82M
Receivables	$581.65K	$372.47K	$120.93K	$48.30K	$132.85K
Inventory	—	—	—	$0.00	—
Current Assets	$1.53M	$1.17M	$3.60M	$6.95M	$3.48M
Total Assets	$6.84M	$6.03M	$9.00M	$9.53M	$6.61M
Current Liabilities	$4.92M	$5.17M	$5.70M	$6.23M	$5.60M
Total Debt	$300.15K	$287.88K	$281.44K	$268.80K	$254.99K
Total Liabilities	$5.17M	$5.41M	$5.92M	$6.44M	$5.80M
Retained Earnings	-$73.52M	-$74.57M	-$77.35M	-$82.35M	-$84.63M
Shareholders' Equity	$1.67M	$621.97K	$3.07M	$3.09M	$814.04K
Working Capital	-$3.39M	-$4.01M	-$2.10M	$723.28K	-$2.12M

ISPC Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	-$1.10M	-$192.23K	-$2.04M	-$916.92K	-$3.36M
Capital Expenditure	—	—	-$1.00M	—	-$700.00K
Free Cash Flow	-$1.10M	-$192.69K	-$3.04M	-$916.92K	-$4.06M
Depreciation & Amortisation	$432.71K	$432.73K	$457.73K	$407.73K	$135.94K
Stock-Based Compensation	$15.90K	$1.80K	$1.80K	$1.76K	$1.03K
Investing Cash Flow	$0.00	-$454.00	-$1.00M	$0.00	-$700.00K
Financing Cash Flow	$0.00	-$1.10K	$5.23M	$5.01M	—
Share Repurchases	$0.00	$0.00	$0.00	—	—
Net Change in Cash	-$1.10M	-$193.79K	$2.19M	$4.10M	-$4.06M

Market Snapshot

About

iSpecimen Inc. operates an online marketplace that connects life science researchers with healthcare specimen providers. The company's technology platform facilitates the procurement of human biospecimens, including blood, tissue, and other biological samples, for use in medical research and drug development. iSpecimen's network includes hospitals, laboratories, and biobanks that supply specimens to pharmaceutical companies, diagnostic companies, and academic researchers. The platform streamlines the traditionally complex and time-consuming process of sourcing biospecimens for research. iSpecimen aims to accelerate medical research and drug discovery by improving access to high-quality human biospecimens.